Press Releases 2012

Press Releases

Quarterly Reports

For a complete listing of Nuvo's Canadian Regulatory filings, visit The System for Electronic Document Analysis and Retrieval (SEDAR) website.

Year

2013 |

2012 |

2011 |

2010

October 31, 2012

Nuvo Third Quarter 2012 Results

October 29, 2012

Nuvo Announces Third Quarter 2012 Results Conference Call

October 22, 2012

Nuvo and Galderma Announce FDA Approval of Pliaglis

September 5, 2012

Nuvo Obtains Additional U.S. Patent for Pennsaid 2%

August 1, 2012

Nuvo Announces Second Quarter 2012 Results

July 26, 2012

Nuvo Receives €4.4 Million Additional Funding To Develop WF10

July 25, 2012

Nuvo Announces New Listing of Synera Patent In FDA Orange Book

July 23, 2012

Nuvo Provides A Pennsaid Franchise Update

July 19, 2012

Nuvo To Receive US$6.0 Million of Milestone Payments from Pliaglis E.U. Approvals

June 14, 2012

Nuvo Provides Pennsaid Commercial Update

May 28, 2012

Nuvo Announces Canadian Licensing Agreement for Synera and a Loan Agreement

May 8, 2012

Nuvo Announces Reply Submitted to Pliaglis FDA Complete Response Letter

May 7, 2012

Nuvo Receives Positive Opinion from the BfArM in E.U. for Pliaglis

May 2, 2012

Nuvo Announces First Quarter 2012 Results

April 18, 2012

Nuvo Announces FDA Issues Complete Response Letter for the Pliaglis sNDA Submission

April 12, 2012

Nuvo Provides Pennsaid Update

March 6, 2012

Nuvo Presenting at Roth Capital Partners Conference

February 29, 2012

Nuvo Announces 2011 Fourth Quarter & Year-End Results

February 23, 2012

Nuvo Announces Pennsaid Franchise Update

February 21, 2012

Nuvo Announces Pliaglis Regulatory Update

February 2, 2012

Nuvo Announces Launch of Synera in the U.S.

January 9, 2012

Nuvo Announces Management Change